Study to evaluate family healthy weight program for childhood obesity in primary care clinics in Louisiana and Tennessee
Grant and Award Announcement
Updates every hour. Last Updated: 15-Jun-2026 18:16 ET (15-Jun-2026 22:16 GMT/UTC)
Pennington Biomedical Research Center, in collaboration with Vanderbilt University Medical Center, has launched a research study, the COACH trial, to test different ways to help children and their families improve their health through lifestyle changes delivered by primary care clinics in communities in Louisiana and Tennessee.
The COACH trial is enrolling 900 children ages 5 to 17 with obesity, which is classified as a BMI at or above the 95th percentile for their age and sex. Patients and their parents are being recruited through urban, suburban and rural doctor’s offices in Tennessee and Louisiana.
Davis Joseph was awarded the 2025 Ciechanover International Biology Award at the Sustainability through Science and Technology Summit 2025 (FLOGEN SIPS 2025) in Cebu, Philippines, for a breakthrough cancer discovery proposing organ-agnostic treatment strategies. His work identifies three universal cancer types based on dysfunctions in p14ARF/p53, DINO lncRNA, and MDM2 activity, and introduces a universal apoptosis network flowsheet built from the analysis of 174 scientific publications. The discovery supports a unified therapeutic framework for treating cancers regardless of the organ in which they originate and is presented as an example of Sustainable Medicine under the FLOGEN Sustainability Framework.
Experiencing abuse or neglect as a child can increase the risk of being victimised by a romantic partner in adulthood, by impacting personality and mental health development, finds a new study led by University College London (UCL) researchers.
The analysis conducted by the research team at Brown’s Center for Advancing Health Policy through Research offers a rare behind-the-scenes look at this market, drawing on data obtained through a Freedom of Information Act request. The study found that broker involvement is both common and growing. In 2014, 36% of first-time Medicare Advantage enrollees used a broker, a figure that rose to 44% by 2022.